Skip to content
The Nexus
DossierENTITY

JAMA

Coverage of JAMA in the Nexus archive.

Earliest in view: Jul 15 · 04:05 UTCMost recent: Jul 15 · 04:05 UTC
Co-mentioned in this coverage
Dr. Reisa Sperlingperson2Mass General Brigham Neuroscience Instituteorganization2p-tau217 testtopic2Alzheimer's diseasetopic2Alzheimer’s Association International Conferenceorganization2
Recent coverage
  • HEALTHJul 15 · 04:05 UTCWDIV CLICKONDETROIT
    Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease

    A blood test measuring p-tau217 levels can predict the risk of Alzheimer's disease in symptom-free older adults, with high levels correlating to a 38% five-year and 78% ten-year risk of cognitive decline. The test is currently used in clinical settings to aid diagnosis but is not yet recommended for healthy individuals, as no interventions exist for early-stage prevention.

  • HEALTHJul 15 · 04:05 UTCWPLG LOCAL 10 MIAMI
    Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease

    A blood test measuring p-tau217 can predict the risk of Alzheimer's disease in healthy older adults, with high levels correlating to a 78% risk of cognitive impairment within 10 years. Researchers caution the test is not yet ready for general use but emphasize its potential to aid drug development and clinical trials.

JAMA · Dossier · The Nexus